Clinical Trials Update: March 23 2006
Osteoarthritis Parkinson's Disease Carotid Artery Disease
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
Radiant Research is seeking people ages 40-75 with pain from osteoarthritis of the knee. Qualified participants will receive study related exams and study drug or placebo at no cost. Compensation up to $500 is available for time and travel. The research site is in St. Louis, Mo.
This study will assess whether the combination of carbidopa/levodopa/entacapone provides greater benefit than the combination of carbidopa/levodopa in treating symptoms of early Parkinson's disease. Candidates must be aged 30 to 80 inclusive at time of idiopathic Parkinson's diagnosis with at least two primary signs of the disease: resting tremor, bradykinesia, or rigidity. Candidates also have not had a diagnosis of Parkinson's for more than five years prior to screening and must not have used levodopa in any formulation. Also must not have used entacapone or tolcapone for more than 30 days or any time within four weeks prior to baseline. The research sites are in Jacksonville, Fla. and Roanoke, Va.
Carotid Artery Disease
People with a carotid artery narrowing who are scheduled to receive a carotid artery stent are asked to participate in a research study being conducted by NYU School of Medicine. Volunteers at least 18 years old who are having an Emboshield and/or Xact stent inserted into the carotid artery may be eligible. The research site is in New York City.
Copyright 2006 CenterWatch. All rights reserved.